Mitochondria in anaesthesia and intensive care;La mitochondrie : rôles et implications en anesthésie-réanimation

Annales Francaises d'Anesthesie et de Reanimation

Volumn 26, Issue 4, 2007, Pages 319-333

  Nouette Gaulain, K ^a,b   Quinart, A ^a   Letellier, T ^b   Sztark, F ^a,b  

^a HÔPITAL PELLEGRIN   (France)

^b INSERM   (France)

Author keywords

anaesthetics; Energy metabolism; Hypoxia; Local anaesthetics; Mitochondria; Mitochondrial K(ATP) channel; Mitochondrial permeability transition pore; Sepsis

Indexed keywords

ANESTHETIC AGENT; PROPOFOL;

ANESTHESIA; DRUG TARGETING; HEART MUSCLE; HUMAN; HYPOXIA; INTENSIVE CARE; ISCHEMIA; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; REPERFUSION INJURY; SEPSIS; SHORT SURVEY;

ANESTHETICS; APOPTOSIS; HUMANS; MITOCHONDRIA; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RESUSCITATION; SIGNAL TRANSDUCTION;

EID: 34247211254     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2007.01.012     Document Type: Short Survey

References (154)

1. Sztark F., Payen J.F., Piriou V., Rigoulet M., Ventura-Clapier R., Mazat J.P., et al. Métabolisme énergétique cellulaire : aspects physiologiques et physiopathologiques. Ann. Fr. Anesth. Reanim. 18 (1999) 261-269
2. Gray M.W., Burger G., and Lang B.F. Mitochondrial evolution. Science 283 (1999) 1476-1481
3. Griparic L., and van der Bliek A.M. The many shapes of mitochondrial membranes. Traffic 2 (2001) 235-244
4. Frey T.G., and Mannella C.A. The internal structure of mitochondria. Trends Biochem. Sci. 25 (2000) 319-324
5. Harris D.A., and Das A.M. Control of mitochondrial ATP synthesis in the heart. Biochem. J. 280 (1991) 561-573
6. Mitchell P. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 191 (1961) 144-148
7. Fillingame R.H. Molecular rotary motors. Science 286 (1999) 1687-1688
8. Chance B., Sies H., and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59 (1979) 527-605
9. Ksenzenko M., Vygodina T.V., Berka V., Ruuge E.K., and Konstantinov A.A. Cytochrome oxidase-catalyzed superoxide generation from hydrogen peroxide. FEBS Lett. 297 (1992) 63-66
10. Beyer R.E. The participation of coenzyme Q in free radical production and antioxidation. Free Radic. Biol. Med. 8 (1990) 545-565
11. Demple B. Radical ideas: genetic responses to oxidative stress. Clin. Exp. Pharmacol. Physiol. 26 (1999) 64-68
12. Hermes-Lima M., and Zenteno-Savin T. Animal response to drastic changes in oxygen availability and physiological oxidative stress. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 133 (2002) 537-556
13. Nakano A., Cohen M.V., and Downey J.M. Ischemic preconditioning: from basic mechanisms to clinical applications. Pharmacol. Ther. 86 (2000) 263-275
14. + channel in the mitochondrial inner membrane. Nature 352 (1991) 244-247
15. Bajgar R., Seetharaman S., Kowaltowski A.J., Garlid K.D., and Paucek P. Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. J. Biol. Chem. 276 (2001) 33369-33374
16. + cycle. Biochim. Biophys. Acta 1606 (2003) 23-41
17. Kim J.S., He L., and Lemasters J.J. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun. 304 (2003) 463-470
18. Suleiman M.S., Halestrap A.P., and Griffiths E.J. Mitochondria: a target for myocardial protection. Pharmacol. Ther. 89 (2001) 29-46
19. Tsujimoto Y., and Shimizu S. The voltage-dependent anion channel: an essential player in apoptosis. Biochimie 84 (2002) 187-193
20. De Giorgi F., Lartigue L., Bauer M.K., Schubert A., Grimm S., Hanson G.T., et al. The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. FASEB J. 16 (2002) 607-609
21. Halestrap A.P., Clarke S.J., and Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc. Res. 61 (2004) 372-385
22. Gateau-Roesch O., Argaud L., and Ovize M. Mitochondrial permeability transition pore and postconditioning. Cardiovasc. Res. 70 (2006) 264-273
23. Nouette-Gaulain K., Forestier F., Malgat M., Marthan R., Mazat J.P., and Sztark F. Effects of bupivacaine on mitochondrial energy metabolism in heart of rats following exposure to chronic hypoxia. Anesthesiology 97 (2002) 1507-1511
24. Irwin W., Fontaine E., Agnolucci L., Penzo D., Betto R., Bortolotto S., et al. Bupivacaine myotoxicity is mediated by mitochondria. J. Biol. Chem. 277 (2002) 12221-12227
25. Bendriss P., Dabadie P., Mazat J.P., Letellier L., and Erny P. Mécanismes d'action moléculaires des anesthésiques locaux. Ann. Fr. Anesth. Reanim. 7 (1988) 189-197
26. Garlid K.D., and Nakashima R.A. Studies on the mechanism of uncoupling by amine local anesthetics. Evidence for mitochondrial proton transport mediated by lipophilic ion pairs. J. Biol. Chem. 258 (1983) 7974-7980
27. Dabadie P., Bendriss P., Erny P., and Mazat J.P. Uncoupling effects of local anesthetics on rat liver mitochondria. FEBS Lett. 226 (1987) 77-82
28. Sun X., and Garlid K.D. On the mechanism by which bupivacaine conducts protons across the membranes of mitochondria and liposomes. J. Biol. Chem. 267 (1992) 19147-19154
29. + in cooperation with hydrophobic anions. J. Biol. Chem. 265 (1990) 7837-7842
30. Sztark F., Ouhabi R., Dabadie P., and Mazat J.P. Effects of the local anesthetic bupivacaine on mitochondrial energy metabolism: change from uncoupling to decoupling depending on the respiration state. Biochem. Mol. Biol. Int. 43 (1997) 997-1003
31. van Dam K., Shinohara Y., Unami A., Yoshida K., and Terada H. Slipping pumps or proton leaks in oxidative phosphorylation. The local anesthetic bupivacaine causes slip in cytochrome c oxidase of mitochondria. FEBS Lett. 277 (1990) 131-133
32. Sztark F., Nouette-Gaulain K., Malgat M., Dabadie P., and Mazat J.P. Absence of stereospecific effects of bupivacaine isomers on heart mitochondrial bioenergetics. Anesthesiology 93 (2000) 456-462
33. Sztark F., Malgat M., Dabadie P., and Mazat J.P. Comparison of the effects of bupivacaine and ropivacaine on heart cell mitochondrial bioenergetics. Anesthesiology 88 (1998) 1340-1349
34. Graf B.M., Abraham I., Eberbach N., Kunst G., Stowe D.F., and Martin E. Differences in cardiotoxicity of bupivacaine and ropivacaine are the result of physicochemical and stereoselective properties. Anesthesiology 96 (2002) 1427-1434
35. Ohmura S., Kawada M., Ohta T., Yamamoto K., and Kobayashi T. Systemic toxicity and resuscitation in bupivacaine-, levobupivacaine-, or ropivacaine-infused rats. Anesth. Analg. 93 (2001) 743-748
36. Weinberg G.L., Palmer J.W., VadeBoncouer T.R., Zuechner M.B., Edelman G., and Hoppel C.L. Bupivacaine inhibits acylcarnitine exchange in cardiac mitochondria. Anesthesiology 92 (2000) 523-528
37. Weinberg G.L., Laurito C.E., Geldner P., Pygon B.H., and Burton B.K. Malignant ventricular dysrhythmias in a patient with isovaleric acidemia receiving general and local anesthesia for suction lipectomy. J. Clin. Anesth. 9 (1997) 668-670
38. Unami A., Shinohara Y., Ichikawa T., and Baba Y. Biochemical and microarray analyses of bupivacaine-induced apoptosis. J. Toxicol. Sci. 28 (2003) 77-94
39. Zink W., Seif C., Bohl J.R., Hacke N., Braun P.M., Sinner B., et al. The acute myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blockades. Anesth. Analg. 97 (2003) 1173-1179
40. Nouette-Gaulain K, Dadure C, Canal M, Sztark F, Capdevilla X. Bupivacaine decreases mitochondrial enzymes activities in muscle after peripheral blockade in rats [abstract]. ASA Meeting 2006: A745.
41. Nouette-Gaulain K, Morau D, Sztark F, Mercier J, Capdevila X. Effects of bupivacaine, L-bupivacaine and ropivacaine on mitochondrial energy metabolism in skeletal muscle tissues after continous peripheral nerve blockade in rats [abstract]. ASA Meeting 2005: A1038.
42. 2+ release channel of skeletal and cardiac muscles. Anesthesiology 90 (1999) 835-843
43. 2+ regulation: potential mechanisms of its myotoxicity. Anesthesiology 97 (2002) 710-716
44. Sirvent P., Nouette-Gaulain K., Morau D., Mercier J., and Capdevila X. Effets des anesthésiques locaux sur l'homéostasie calcique musculaire chez le rat [résumé]. Ann. Fr. Anesth. Reanim. 24 (2005) R438
45. Zink W., and Graf B.M. Local anesthetic myotoxicity. Reg. Anesth. Pain Med. 29 (2004) 333-340
46. McLoon L.K., Nguyen L.T., and Wirtschafter J. Time course of the regenerative response in bupivacaine injured orbicularis oculi muscle. Cell Tissue Res. 294 (1998) 439-447
47. Duguez S., Feasson L., Denis C., and Freyssenet D. Mitochondrial biogenesis during skeletal muscle regeneration. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E802-E809
48. Hogan Q., Dotson R., Erickson S., Kettler R., and Hogan K. Local anesthetic myotoxicity: a case and review. Anesthesiology 80 (1994) 942-947
49. 2+ regulation in murine skeletal muscle fibers. Anesthesiology 102 (2005) 793-798
50. Koide R., Honda M., Kora Y., and Ozawa T. Diplopia after cataract surgery. J. Cataract Refract. Surg. 26 (2000) 1198-1204
51. Gomez-Arnau J.I., Yanguela J., Gonzalez A., Andres Y., Garcia del Valle S., Gili P., et al. Anaesthesia-related diplopia after cataract surgery. Br. J. Anaesth. 90 (2003) 189-193
52. Lambert L.A., Lambert D.H., and Strichartz G.R. Irreversible conduction block in isolated nerve by high concentrations of local anesthetics. Anesthesiology 80 (1994) 1082-1093
53. Radwan I.A., Saito S., and Goto F. The neurotoxicity of local anesthetics on growing neurons: a comparative study of lidocaine, bupivacaine, mepivacaine, and ropivacaine. Anesth. Analg. 94 (2002) 319-324
54. Johnson M.E., Saenz J.A., DaSilva A.D., Uhl C.B., and Gores G.J. Effect of local anesthetic on neuronal cytoplasmic calcium and plasma membrane lysis (necrosis) in a cell culture model. Anesthesiology 97 (2002) 1466-1476
55. Johnson M.E., Uhl C.B., Spittler K.H., Wang H., and Gores G.J. Mitochondrial injury and caspase activation by the local anesthetic lidocaine. Anesthesiology 101 (2004) 1184-1194
56. Gold M.S., Reichling D.B., Hampl K.F., Drasner K., and Levine J.D. Lidocaine toxicity in primary afferent neurons from the rat. J. Pharmacol. Exp. Ther. 285 (1998) 413-421
57. Auroy Y., Benhamou D., Bargues L., Ecoffey C., Falissard B., Mercier F.J., et al. Major complications of regional anesthesia in France: The SOS Regional Anesthesia Hotline Service. Anesthesiology 97 (2002) 1274-1280
58. Heavner J.E., Dryden Jr. C.F., Sanghani V., Huemer G., Bessire A., and Badgwell J.M. Severe hypoxia enhances central nervous system and cardiovascular toxicity of bupivacaine in lightly anesthetized pigs. Anesthesiology 77 (1992) 142-147
59. Weinberg G. Lipid infusion resuscitation for local anesthetic toxicity: proof of clinical efficacy. Anesthesiology 105 (2006) 7-8
60. Weinberg G., Ripper R., Feinstein D.L., and Hoffman W. Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg. Anesth. Pain Med. 28 (2003) 198-202
61. Weinberg G.L., Ripper R., Murphy P., Edelman L.B., Hoffman W., Strichartz G., et al. Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart. Reg. Anesth. Pain Med. 31 (2006) 296-303
62. Morgan P.G., Hoppel C.L., and Sedensky M.M. Mitochondrial defects and anesthetic sensitivity. Anesthesiology 96 (2002) 1268-1270
63. Hanley P.J., Ray J., Brandt U., and Daut J. Halothane, isoflurane and sevoflurane inhibit NADH: ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J. Physiol. 544 (2002) 687-693
64. Chiari P., Bouvet F., and Piriou V. Préconditionnement myocardique induit par les agents anesthésiques halogénés : bases fondamentales et implications cliniques. Ann. Fr. Anesth. Reanim. 24 (2005) 383-396
65. Weber N.C., and Schlack W. The concept of anaesthetic-induced cardioprotection: mechanisms of action. Best Pract. Res. Clin. Anaesthesiol. 19 (2005) 429-443
66. Tanaka K., Ludwig L.M., Kersten J.R., Pagel P.S., and Warltier D.C. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 100 (2004) 707-721
67. Sato T., Sasaki N., O'Rourke B., and Marban E. Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: a key step in ischemic preconditioning?. Circulation 102 (2000) 800-805
68. Oldenburg O., Qin Q., Sharma A.R., Cohen M.V., Downey J.M., and Benoit J.N. Acetylcholine leads to free radical production dependent on K(ATP) channels, G(i) proteins, phosphatidylinositol 3-kinase and tyrosine kinase. Cardiovasc. Res. 55 (2002) 544-552
69. Fryer R.M., Auchampach J.A., and Gross G.J. Therapeutic receptor targets of ischemic preconditioning. Cardiovasc. Res. 55 (2002) 520-525
70. Domenech R., Macho P., Schwarze H., and Sanchez G. Exercise induces early and late myocardial preconditioning in dogs. Cardiovasc. Res. 55 (2002) 561-566
71. Wang Q.D., Pernow J., Sjoquist P.O., and Ryden L. Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc. Res. 55 (2002) 25-37
72. Neckar J., Szarszoi O., Koten L., Papousek F., Ost'adal B., Grover G.J., et al. Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats. Cardiovasc. Res. 55 (2002) 567-575
73. Eells J.T., Henry M.M., Gross G.J., and Baker J.E. Increased mitochondrial K(ATP) channel activity during chronic myocardial hypoxia: is cardioprotection mediated by improved bioenergetics?. Circ. Res. 87 (2000) 915-921
74. Zaugg M., Lucchinetti E., Uecker M., Pasch T., and Schaub M.C. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br. J. Anaesth. 91 (2003) 551-565
75. Zaugg M., Schaub M.C., and Foex P. Myocardial injury and its prevention in the perioperative setting. Br. J. Anaesth. 93 (2004) 21-33
76. Zaugg M., Lucchinetti E., Spahn D.R., Pasch T., and Schaub M.C. Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways. Anesthesiology 97 (2002) 4-14
77. Kohro S., Hogan Q.H., Nakae Y., Yamakage M., and Bosnjak Z.J. Anesthetic effects on mitochondrial ATP-sensitive K channel. Anesthesiology 95 (2001) 1340-1435
78. + channels reconstituted in lipid bilayers. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H1865-H1871
79. Hanouz J.L., Massetti M., Guesne G., Chanel S., Babatasi G., Rouet R., et al. In vitro effects of desflurane, sevoflurane, isoflurane, and halothane in isolated human right atria. Anesthesiology 92 (2000) 116-124
80. Piriou V., Ross S., Pigott D., Evans R., and Foex P. Beneficial effect of concomitant administration of isoflurane and nicorandil. Br. J. Anaesth. 79 (1997) 68-77
81. Zaugg M., Lucchinetti E., Garcia C., Pasch T., Spahn D.R., and Schaub M.C. Anaesthetics and cardiac preconditioning. Part II. Clinical implications. Br. J. Anaesth. 91 (2003) 566-576
82. Ludwig L.M., Patel H.H., Gross G.J., Kersten J.R., Pagel P.S., and Warltier D.C. Morphine enhances pharmacological preconditioning by isoflurane: role of mitochondrial K(ATP) channels and opioid receptors. Anesthesiology 98 (2003) 705-711
83. Piriou V., Chiari P., Knezynski S., Bastien O., Loufoua J., Lehot J.J., et al. Prevention of isoflurane-induced preconditioning by 5-hydroxydecanoate and gadolinium: possible involvement of mitochondrial adenosine triphosphate-sensitive potassium and stretch-activated channels. Anesthesiology 93 (2000) 756-764
84. De Hert S.G., Turani F., Mathur S., and Stowe D.F. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth. Analg. 100 (2005) 1584-1593
85. Piriou V., Chiari P., Lhuillier F., Bastien O., Loufoua J., Raisky O., et al. Pharmacological preconditioning: comparison of desflurane, sevoflurane, isoflurane and halothane in rabbit myocardium. Br. J. Anaesth. 89 (2002) 486-491
86. Mullenheim J., Ebel D., Bauer M., Otto F., Heinen A., Frassdorf J., et al. Sevoflurane confers additional cardioprotection after ischemic late preconditioning in rabbits. Anesthesiology 99 (2003) 624-631
87. De Hert S.G., Cromheecke S., ten Broecke P.W., Mertens E., De Blier I.G., Stockman B.A., et al. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 99 (2003) 314-323
88. De Hert S.G., ten Broecke P.W., Mertens E., Van Sommeren E.W., De Blier I.G., Stockman B.A., et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 97 (2002) 42-49
89. Julier K., da Silva R., Garcia C., Bestmann L., Frascarolo P., Zollinger A., et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 98 (2003) 1315-1327
90. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H579-H588
91. Ebel D., Preckel B., You A., Mullenheim J., Schlack W., and Thamer V. Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia. Br. J. Anaesth. 88 (2002) 828-835
92. Domoki F., Perciaccante J.V., Veltkamp R., Bari F., and Busija D.W. Mitochondrial potassium channel opener diazoxide preserves neuronal-vascular function after cerebral ischemia in newborn pigs. Stroke 30 (1999) 2713-2718
93. Lee H.T., Ota-Setlik A., Fu Y., Nasr S.H., and Emala C.W. Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 101 (2004) 1313-1324
94. Fink M.P. Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit. Care Clin. 17 (2001) 219-237
95. Branca D., Roberti M.S., Lorenzin P., Vincenti E., and Scutari G. Influence of the anesthetic 2,6-diisopropylphenol on the oxidative phosphorylation of isolated rat liver mitochondria. Biochem. Pharmacol. 42 (1991) 87-90
96. Rigoulet M., Devin A., Averet N., Vandais B., and Guerin B. Mechanisms of inhibition and uncoupling of respiration in isolated rat liver mitochondria by the general anesthetic 2,6-diisopropylphenol. Eur. J. Biochem. 241 (1996) 280-285
97. Stevanato R., Momo F., Marian M., Rigobello M.P., Bindoli A., Bragadin M., et al. Combined effect of propofol and GSNO on oxidative phosphorylation of isolated rat liver mitochondria. Nitric Oxide 5 (2001) 158-165
98. Schenkman K.A., and Yan S. Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy. Crit. Care Med. 28 (2000) 172-177
99. Cudic M., and Ducrocq C. Transformations of 2,6-diisopropylphenol by NO-derived nitrogen oxides, particularly peroxynitrite. Nitric Oxide 4 (2000) 147-156
100. Kohnen S.L., Mouithys-Mickalad A.A., Deby-Dupont G.P., Deby C.M., Hans P., Lamy M.L., et al. Investigation of the reaction of peroxynitrite with propofol at acid pH: predominant production of oxidized, nitrated, and halogenated derivatives. Nitric Oxide 8 (2003) 170-181
101. Momo F., Fabris S., Wisniewska A., Fiore C., Bindoli A., Scutari G., et al. Correlation between fluidising effects on phospholipid membranes and mitochondrial respiration of propofol and p-nitrosophenol homologues. Biophys. Chem. 103 (2003) 213-222
102. Tsuchiya H. Structure-specific membrane-fluidizing effect of propofol. Clin. Exp. Pharmacol. Physiol. 28 (2001) 292-299
103. Stevanato R., Momo F., Marian M., Rigobello M.P., Bindoli A., Bragadin M., et al. Effects of nitrosopropofol on mitochondrial energy-converting system. Biochem. Pharmacol. 64 (2002) 1133-1138
104. Wolf A., Weir P., Segar P., Stone J., and Shield J. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 357 (2001) 606-607
105. Vasile B., Rasulo F., Candiani A., and Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 29 (2003) 1417-1425
106. Bray R.J. Propofol infusion syndrome in children. Paediatr. Anaesth. 8 (1998) 491-499
107. ®) for nonprocedural (long-term) sedation and literature review. Anesthesiology 105 (2006) 1047-1051
108. Culp K.E., Augoustides J.G., Ochroch A.E., and Milas B.L. Clinical management of cardiogenic shock associated with prolonged propofol infusion. Anesth. Analg. 99 (2004) 221-226
109. Uezono S., Hotta Y., Takakuwa Y., and Ozaki M. Acquired carnitine deficiency: a clinical model for propofol infusion syndrome?. Anesthesiology 103 (2005) 909
110. Kawano T., Oshita S., Tsutsumi Y., Tomiyama Y., Kitahata H., Kuroda Y., et al. Clinically relevant concentrations of propofol have no effect on adenosine triphosphate-sensitive potassium channels in rat ventricular myocytes. Anesthesiology 96 (2002) 1472-1477
111. Sztark F., Ichas F., Ouhabi R., Dabadie P., and Mazat J.P. Effects of the anaesthetic propofol on the calcium-induced permeability transition of rat heart mitochondria: direct pore inhibition and shift of the gating potential. FEBS Lett. 368 (1995) 101-104
112. Javadov S.A., Lim K.H., Kerr P.M., Suleiman M.S., Angelini G.D., and Halestrap A.P. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc. Res. 45 (2000) 360-369
113. Chen R.M., Wu C.H., Chang H.C., Wu G.J., Lin Y.L., Sheu J.R., et al. Propofol suppresses macrophage functions and modulates mitochondrial membrane potential and cellular adenosine triphosphate synthesis. Anesthesiology 98 (2003) 1178-1185
114. Tsuchiya M., Asada A., Maeda K., Ueda Y., Sato E.F., Shindo M., et al. Propofol vs midazolam regarding their antioxidant activities. Am. J. Respir. Crit. Care Med. 163 (2001) 26-31
115. Tsuchiya M., Asada A., Kasahara E., Sato E.F., Shindo M., and Inoue M. Antioxidant protection of propofol and its recycling in erythrocyte membranes. Am. J. Respir. Crit. Care Med. 165 (2002) 54-60
116. Delogu G., Antonucci A., Moretti S., Marandola M., Tellan G., Signore M., et al. Oxidative stress and mitochondrial glutathion in human lymphocytes exposed to clinically relevant anesthetic drug concentrations. J. Clin. Anesth. 16 (2004) 189-194
117. Song H.K., and Jeong D.C. The effect of propofol on cytotoxicity and apoptosis of lipopolysaccharide-treated mononuclear cells and lymphocytes. Anesth. Analg. 98 (2004) 1724-1728
118. Tsuchiya M., Asada A., Arita K., Utsumi T., Yoshida T., Sato E.F., et al. Induction and mechanism of apoptotic cell death by propofol in HL-60 cells. Acta Anaesthesiol. Scand. 46 (2002) 1068-1074
119. Ronco J.J., Fenwick J.C., Wiggs B.R., Phang P.T., Russell J.A., and Tweeddale M.G. Oxygen consumption is independent of increases in oxygen delivery by dobutamine in septic patients who have normal or increased plasma lactate. Am. Rev. Respir. Dis. 147 (1993) 25-31
120. Brealey D., Brand M., Hargreaves I., Heales S., Land J., Smolenski R., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 (2002) 219-223
121. L'Her E., and Sebert P. A global approach to energy metabolism in an experimental model of sepsis. Am. J. Respir. Crit. Care Med. 164 (2001) 1444-1447
122. Crouser E.D., Julian M.W., Blaho D.V., and Pfeiffer D.R. Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit. Care Med. 30 (2002) 276-284
123. Adrie C., Bachelet M., Vayssier-Taussat M., Russo-Marie F., Bouchaert I., Adib-Conquy M., et al. Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am. J. Respir. Crit. Care Med. 164 (2001) 389-395
124. Suliman H.B., Welty-Wolf K.E., Carraway M.S., Schwartz D.A., Hollingsworth J.W., and Piantadosi C.A. Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli. FASEB J. 19 (2005) 1531-1533
125. Dahm C.C., Moore K., and Murphy M.P. Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria. J. Biol. Chem. 281 (2006) 10056-10065
126. Wallace D.C. Mitochondrial diseases in man and mouse. Science 283 (1999) 1482-1488
127. DiMauro S., and Schon E.A. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 348 (2003) 2656-2668
128. Shoffner J.M., Lott M.T., Lezza A.M., Seibel P., Ballinger S.W., and Wallace D.C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 61 (1990) 931-937
129. Rossignol R., Faustin B., Rocher C., Malgat M., Mazat J.P., and Letellier T. Mitochondrial threshold effects. Biochem. J. 370 (2003) 751-762
130. Shipton E.A., and Prosser D.O. Mitochondrial myopathies and anaesthesia. Eur. J. Anaesthesiol. 21 (2004) 173-178
131. Cheam E.W., and Critchley L.A. Anesthesia for a child with complex I respiratory chain enzyme deficiency. J. Clin. Anesth. 10 (1998) 524-527
132. Cohen P.J. Effect of anesthetics on mitochondrial function. Anesthesiology 39 (1973) 153-164
133. Kayser E.B., Morgan P.G., and Sedensky M.M. Mitochondrial complex I function affects halothane sensitivity in Caenorhabditis elegans. Anesthesiology 101 (2004) 365-372
134. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 (2003) 1140-1142
135. Lowell B.B., and Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 307 (2005) 384-387
136. Petersen K.F., Dufour S., Befroy D., Garcia R., and Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350 (2004) 664-671
137. Joseph J.W., Koshkin V., Zhang C.Y., Wang J., Lowell B.B., Chan C.B., et al. Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 51 (2002) 3211-3219
138. Zhang C.Y., Baffy G., Perret P., Krauss S., Peroni O., Grujic D., et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105 (2001) 745-755
139. Chan C.B., De Leo D., Joseph J.W., McQuaid T.S., Ha X.F., Xu F., et al. Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 50 (2001) 1302-1310
140. 2 sensing in hypoxic pulmonary vasoconstriction: the mitochondrial door re-opens. Respir. Physiol. Neurobiol. 132 (2002) 81-91
141. 2 sensor in rat pulmonary vasculature. Circ. Res. 73 (1993) 1100-1112
142. Marshall C., Mamary A.J., Verhoeven A.J., and Marshall B.E. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am. J. Respir. Cell Mol. Biol. 15 (1996) 633-644
143. Leach R.M., Hill H.M., Snetkov V.A., Robertson T.P., and Ward J.P. Divergent roles of glycolysis and the mitochondrial electron transport chain in hypoxic pulmonary vasoconstriction of the rat: identity of the hypoxic sensor. J. Physiol. 536 (2001) 211-224
144. Waypa G.B., Chandel N.S., and Schumacker P.T. Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ. Res. 88 (2001) 1259-1266
145. Nouette-Gaulain K., Malgat M., Rocher C., Savineau J.P., Marthan R., Mazat J.P., et al. Time course of differential mitochondrial energy metabolism adaptation to chronic hypoxia in right and left ventricles. Cardiovasc. Res. 66 (2005) 132-140
146. Novel-Chate V., Mateo P., Saks V.A., Hoerter J.A., and Rossi A. Chronic exposure of rats to hypoxic environment alters the mechanism of energy transfer in myocardium. J. Mol. Cell. Cardiol. 30 (1998) 1295-1303
147. Rumsey W.L., Abbott B., Bertelsen D., Mallamaci M., Hagan K., Nelson D., et al. Adaptation to hypoxia alters energy metabolism in rat heart. Am. J. Physiol. 276 (1999) H71-H80
148. Daneshrad Z., Garcia-Riera M.P., Verdys M., and Rossi A. Differential responses to chronic hypoxia and dietary restriction of aerobic capacity and enzyme levels in the rat myocardium. Mol. Cell. Biochem. 210 (2000) 159-166
149. Bailey J.R., and Driedzic W.R. Decreased total ventricular and mitochondrial protein synthesis during extended anoxia in turtle heart. Am. J. Physiol. 271 (1996) R1660-R1667
150. Ou L.C., and Leiter J.C. Effects of exposure to a simulated altitude of 5500 m on energy metabolic pathways in rats. Respir. Physiol. Neurobiol. 141 (2004) 59-71
151. Gosker H.R., Wouters E.F., van der Vusse G.J., and Schols A.M. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am. J. Clin. Nutr. 71 (2000) 1033-1047
152. Jakobsson P., Jorfeldt L., and Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 151 (1995) 374-377
153. Abdel-aleem S., St Louis J., Hendrickson S.C., El-Shewy H.M., El-Dawy K., Taylor D.A., et al. Regulation of carbohydrate and fatty acid utilization by L-carnitine during cardiac development and hypoxia. Mol. Cell. Biochem. 180 (1998) 95-103
154. Szewczyk A., and Wojtczak L. Mitochondria as a pharmacological target. Pharmacol. Rev. 54 (2002) 101-127